These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7983088)

  • 1. Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy.
    Häfeli UO; Sweeney SM; Beresford BA; Sim EH; Macklis RM
    J Biomed Mater Res; 1994 Aug; 28(8):901-8. PubMed ID: 7983088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
    Häfeli UO; Sweeney SM; Beresford BA; Humm JL; Macklis RM
    Nucl Med Biol; 1995 Feb; 22(2):147-55. PubMed ID: 7767307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.
    Tom JW; Debenedetti PG
    Biotechnol Prog; 1991; 7(5):403-11. PubMed ID: 1369363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron-activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors.
    Mumper RJ; Ryo UY; Jay M
    J Nucl Med; 1991 Nov; 32(11):2139-43. PubMed ID: 1941151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradation and antitumour effect of adriamycin-containing poly(L-lactic acid) microspheres.
    Ike O; Shimizu Y; Ikada Y; Watanabe S; Natsume T; Wada R; Hyon SH; Hitomi S
    Biomaterials; 1991 Oct; 12(8):757-62. PubMed ID: 1799651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid).
    Burt HM; Jackson JK; Bains SK; Liggins RT; Oktaba AM; Arsenault AL; Hunter WL
    Cancer Lett; 1995 Jan; 88(1):73-9. PubMed ID: 7531612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal characteristics of poly (DL-lactic acid) microspheres containing neurotensin analogue.
    Yamakawa I; Ashizawa K; Tsuda T; Watanabe S; Hayashi M; Awazu S
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2870-2. PubMed ID: 1464121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of superparamagnetic iron oxide nanoparticles in poly-(lactide-co-glycolic acid) microspheres for biomedical applications.
    Gun S; Edirisinghe M; Stride E
    Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3129-37. PubMed ID: 23706192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic nanoparticles-loaded PLA/PEG microspheres as drug carriers.
    Frounchi M; Shamshiri S
    J Biomed Mater Res A; 2015 May; 103(5):1893-8. PubMed ID: 25203941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.
    Bodmeier R; McGinity JW
    J Microencapsul; 1988; 5(4):325-30. PubMed ID: 3236152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterisation of polymeric microparticle of poly(d,l-lactic acid) loaded with holmium acetylacetonate.
    de Azevedo MBM; de Melo VHS; Soares CRJ; Miyamoto DM; Katayama RA; Squair PL; Barros CHN; Tasic L
    J Microencapsul; 2018 May; 35(3):281-291. PubMed ID: 29790801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-(D,L-lactic acid) microspheres incorporating histological dyes for intra-pulmonary histopathological investigations.
    Armstrong DJ; Elliott PN; Ford JL; Gadsdon D; McCarthy GP; Rostron C; Worsley MD
    J Pharm Pharmacol; 1996 Mar; 48(3):258-62. PubMed ID: 8737050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
    Vergote I; Larsen RH; de Vos L; Nesland JM; Bruland O; Bjørgum J; Alstad J; Tropé C; Nustad K
    Gynecol Oncol; 1992 Dec; 47(3):366-72. PubMed ID: 1473751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques.
    Nijsen JF; Zonnenberg BA; Woittiez JR; Rook DW; Swildens-van Woudenberg IA; van Rijk PP; van het Schip AD
    Eur J Nucl Med; 1999 Jul; 26(7):699-704. PubMed ID: 10398817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
    Allison C
    Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
    Eniola AO; Hammer DA
    Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.